epigenetics

Awards Boost Dementia Research at Exeter

The Complex Disease Epigenetics Group, within the University of Exeter Medical School, received awards totaling more than $250,000 to aid in its cutting-edge genomic research to better understand the causes of dementia.
Ocean Conservation

Institute Spearheads Effort to Protect Atlantic Menhaden

Dr. Ellen Pikitch, executive director of the Institute for Ocean Conservation Science, gathered signatures of more than 100 global scientists on a letter to the Atlantic States Marine Fisheries Commission seeking protection of the Atlantic Menhaden's role as prey.
IGTRCN

Database Developed to Aggregate Data on Anti-CRISPR Proteins

Insect Genetic Technologies RCN reports on a new, manually created, searchable, and browsable database that scientists (Dong et al.)  constructed that aggregates current data on anti-CRISPR proteins.
I'm-migration

I'm-migration has a new website!

Re-Imagining Migration is a new organization created to foster understanding and the successful inclusion of migrant youth across the globe.
WormGUIDES

WormGUIDES has a new website!

The mission of the WormGUIDES website is to create a novel systems-level resource that will facilitate examination of cellular decisions in the developing nervous system of this nematode, enhancing its value for providing new insights in development, neuroscience and disease.
Voices of Democracy

Voices of Democracy

Voices of Democracy (VOD) originated in conversations among the founding directors of the project: Shawn J. Parry-Giles, Robert Gaines, J. Michael Hogan, Rosa Eberly, and Martin J. Medhurst. In the summer of 2005, the University of Maryland (UM) and the Pennsylvania State University (PSU) were awarded a $195,023 grant from the National Endowment for the Humanities (NEH) in support of the project.
University Miami Memory

U. of Miami School of Medicine Launches Clinical Trial for Alzheimer's Treatment

Neurologists at The University of Miami are launching a clinical trial for a revolutionary Alzheimer's treatment, which will be the first in the U.S that utilizes mesenchymal stem cells.